Zhuriheng pills improve adipose tissue dysfunction and inflammation by modulating PPARγ to stabilize atherosclerotic plaques
Our results demonstrated that ZRH stabilizes atherosclerotic plaques by ameliorating adipose tissue dysfunction and inflammation by regulating the PPARγ pathway.
Authors
- Pengwei Zhao (ORCID: https://orcid.org/0000-0002-2526-5705)
- Shengsang Na (ORCID: https://orcid.org/0000-0003-4318-229X)
- Qiang Wei (ORCID: https://orcid.org/0000-0001-5194-8262)
- Peifeng Xue (ORCID: https://orcid.org/0000-0002-5702-5263)
- Guanlin Yang
- Xiaoning Wang (ORCID: https://orcid.org/0000-0002-9806-9537)
- Xuan Zhang (ORCID: https://orcid.org/0009-0008-5203-0355)
- Jingkun Lu
- Zhimin Liu (ORCID: https://orcid.org/0009-0004-8303-8684)
- Xin Dong
- Ren Bu
- Qiong Zhai
- Yuewu Wang (ORCID: https://orcid.org/0000-0002-1158-879X)
- Fangyuan Liang
Institutions
- Inner Mongolia University for Nationalities (CN)
- Chifeng University (CN)
- Nantong University (CN)
- Zaozhuang Municipal Hospital (CN)
- Inner Mongolia Medical University (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-10-20
- DOI
- https://doi.org/10.3389/fphar.2025.1576521
- Primary Topic
- Peroxisome Proliferator-Activated Receptors
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Inner Mongolia Medical University
- National Natural Science Foundation of China